Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 81CNS 16Gynecologic 15Genitourinary 10Sarcoma 8Gastrointestinal 6Tumor-Agnostic 4Thoracic 4Head & Neck 2Plasma cell 1Other solid neoplasm 1Other neoplasm 1NET 1Lymphoid 1Endocrine 1

Conditions

Malignant Neoplasms of Female Genital Organs 1

Interventions

fludarabine 5Educational Status 5fludarabine phosphate 4Whole-Body Irradiation 4Mycophenolic Acid 4Methods 4Melphalan 4Magnetic Resonance Spectroscopy 4Early Intervention, Educational 4Cyclophosphamide 4Busulfan 4Biopsy 4Taxes 3Tacrolimus 3Specimen Handling 3Peripheral Blood Stem Cell Transplantation 3Paclitaxel 3Interviews as Topic 3venetoclax 2Sirolimus 2Patient Reported Outcome Measures 2Nivolumab 2Mesna 2Health Promotion 2Colposcopy 2Cisplatin 2Aminolevulinic Acid 2Albumin-Bound Paclitaxel 2toripalimab 1tirbanibulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
abemaciclib × Other neoplasm × 1 year × Clear all
NCT03531645 2026-03-05

Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
18 enrolled
Other neoplasm

Malignant Neoplasms of Female Genital Organs

Data powered by HemOnc (CC BY 4.0) Colophon âš¡